Seattle biotech startup Curi Bio lands $10M to expand its R&D support for drug discovery Seattle biotech startup Curi Bio today announced $10 million in new funding. The company enables the screening of new drugs using 3D tissue models. Read More
Stem cell startup Silene Biotech acquired by NanoSurface Biomedical in all-Seattle deal NanoSurface Biomedical has snapped up Silene Biotech in a union of two Seattle startups that bets on the growing importance… Read More
